Trimetazidine – Cardiology MCQ
Trimetazidine is an antianginal agent which acts by inhibition of:
A. Beta oxidation of fatty acids
B. Anaerobic metabolism of glucose
C. Calcium channels
D. Beta adrenergic receptors
Please check the YouTube video above for discussion
Related Posts
-
Isolated diastolic dysfunction – Cardiology MCQ
No Comments | Apr 22, 2012 -
Osler sign – Cardiology MCQ
No Comments | May 1, 2011 -
Statin adverse effect – Cardiology MCQ
7 Comments | Jun 30, 2018 -
Flash pulmonary edema in renal artery stenosis – Cardiology MCQ
No Comments | Sep 12, 2014
About The Author
Johnson Francis
Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal